CLINICAL24 Forum: MRD in Liquid Biopsy – Tackling Validation Challenges and Defining Best Practice

We use cookies to collect information, and enable our website to work properly. Please tell us whether you accept cookies by clicking the button below. If you decide not to accept cookies, our site may not work as expected and some information may not be available.

Click here for more information on cookies, including how to remove them.

Accept Cookies

5th November 2026

Date: Thursday 5th November 2026
Time: 16:00 GMT
Speaker: Jenni Fairley
Location: Online
Duration: 60 minutes
Cost: Free to attend

About the Event

The CLINICAL24 Forum will explore the challenges and considerations involved in validating molecular residual disease (MRD) testing using liquid biopsy.

The discussion will focus on analytical validation, standardisation, reproducibility and the practical considerations of implementing MRD testing in routine laboratories. It will provide an opportunity to consider current challenges and approaches to establishing best practice in this evolving area of molecular diagnostics.

Join Jenni Fairley for this online discussion on the importance of robust validation and consistent practices in supporting the reliability and wider adoption of MRD testing.

Learn more about the event: Here

Follow GenQA on LinkedIn to stay up to date with the latest information.

<< BACK

Events

About the Event